<p>Side population of CSCs as analyzed by FACS and their Hoechst 33342 dye efflux inhibition by reserpine in MDA-MB-231 (A) and 4T1 (B). Dose curve of IMD-0354 on side population in MDA-MB-231 (C) and 4T1 (D). Data are shown as mean ± SEM.</p
<p>Viability of MDA-MB-231 cells was assessed by MTT assay after treatment with doxorubicin for 24 h...
<p>(A) Cell viability after CSC treatment. Confluent IMR-90 cells were treated with CSC (or mock tre...
<p>Control or ch-4C5 treated MDA-MB-453 cells were labeled with the fluorescent dye DiO and injected...
<p>Viability of MDA-MB-231 cells was assessed by MTT assay after treatment with IMD-0354 for 24 h (A...
Although early detection of breast cancer improved in recent years, prognosis of patients with late ...
(A, B) Tumor organoid cells from p53/BRAC1-deficient tumor model (A) or C3(1)-Tag model (B) were inj...
<p>Results are presented as median inhibitory concentrations (IC<sub>50</sub> values in μg/ml ± S.E....
<p>A549 (A) and H1299 (B) cells were incubated with with different concentrations of CVT-11127 (CVT)...
<p>(A) The growing trends of tumor cells under MBMSC or NBMSC environment with or without niche inhi...
<p>(<b>A</b>) BT474-tet-shMED1, ZR75-1-tet-shMED1 and MCF-7-tet-shMED1 cells were treated with vehic...
<p>Viability of 4T1 or FL4T1 cells was assessed by the MTT assay after treatment with: doxorubicin f...
<p>FACS-based Hoechst extrusion assay shows the size of side population (SP) in 10B cells incubated ...
CITATION: Mqoco, T., et al. 2019. A combination of an antimitotic and a bromodomain 4 inhibitor syne...
<p><b>Copyright information:</b></p><p>Taken from "1,1-Bis(3'-indolyl)-1-(-biphenyl)methane inhibits...
<p>(A) Tumor volume fold change over time (14 days). Decrease in mean tumor volume + SEM was observe...
<p>Viability of MDA-MB-231 cells was assessed by MTT assay after treatment with doxorubicin for 24 h...
<p>(A) Cell viability after CSC treatment. Confluent IMR-90 cells were treated with CSC (or mock tre...
<p>Control or ch-4C5 treated MDA-MB-453 cells were labeled with the fluorescent dye DiO and injected...
<p>Viability of MDA-MB-231 cells was assessed by MTT assay after treatment with IMD-0354 for 24 h (A...
Although early detection of breast cancer improved in recent years, prognosis of patients with late ...
(A, B) Tumor organoid cells from p53/BRAC1-deficient tumor model (A) or C3(1)-Tag model (B) were inj...
<p>Results are presented as median inhibitory concentrations (IC<sub>50</sub> values in μg/ml ± S.E....
<p>A549 (A) and H1299 (B) cells were incubated with with different concentrations of CVT-11127 (CVT)...
<p>(A) The growing trends of tumor cells under MBMSC or NBMSC environment with or without niche inhi...
<p>(<b>A</b>) BT474-tet-shMED1, ZR75-1-tet-shMED1 and MCF-7-tet-shMED1 cells were treated with vehic...
<p>Viability of 4T1 or FL4T1 cells was assessed by the MTT assay after treatment with: doxorubicin f...
<p>FACS-based Hoechst extrusion assay shows the size of side population (SP) in 10B cells incubated ...
CITATION: Mqoco, T., et al. 2019. A combination of an antimitotic and a bromodomain 4 inhibitor syne...
<p><b>Copyright information:</b></p><p>Taken from "1,1-Bis(3'-indolyl)-1-(-biphenyl)methane inhibits...
<p>(A) Tumor volume fold change over time (14 days). Decrease in mean tumor volume + SEM was observe...
<p>Viability of MDA-MB-231 cells was assessed by MTT assay after treatment with doxorubicin for 24 h...
<p>(A) Cell viability after CSC treatment. Confluent IMR-90 cells were treated with CSC (or mock tre...
<p>Control or ch-4C5 treated MDA-MB-453 cells were labeled with the fluorescent dye DiO and injected...
DOI
Add to ORKG